Home/ Supplements/ Electrolytes/ Arteriozyme

Arteriozyme

product on market Tablet or Pill Energique Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains minerals like calcium, phosphorus, and zinc, alongside pancreatin and rutin, which support metabolic and vascular functions. Research evidence for this specific combination is limited, as indicated by the low evidence coverage. These ingredients are generally recognized as safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Arteriozyme
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
90
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
103 mg (8% DV)
78 mg (6% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
8 mg (76% DV)
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
Pancreatin
300 mg
102 mg
Market median: 500.0mg (19 products)
Thymus Substance
70 mg
Arteriozyme Proprietary Blend
53 mg
Trypsin
35 mg
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
20 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)

Other Ingredients

Microcrystalline Cellulose Hydroxypropyl Cellulose Croscarmellose Sodium Magnesium Stearate Hypromellose Polyethylene Glycol Silica Stearic Acid
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, adults two tablets 3 times daily away from meals or as directed by a health professional.

Warnings & Precautions

Warnings: If pregnant, breast-feeding, or have a medical condition, ask a health professional before use.

Consult a physician for use in children under 12 years of age. Keep out of reach of children.

Do not use if tamper evident seal is broken or missing.

Contains Egg, milk, and sulfites. If you have an allergy to eggs, milk or sulfites, you should not use this product. If you have an allergy to eggs, milk or sulfites, you should not use this product.

Additional Information

Store in a cool, dry place.

Metadata

Product Details

DSLD Entry Date2024-08-22
Product TypeOther Combinations
FormTablet or Pill
DSLD ID318436
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.